These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 14654634)

  • 1. Attention-deficit/hyperactivity disorder treatment and later drug use.
    Furman L
    Pediatrics; 2003 Dec; 112(6 Pt 1):1459-60; author reply 1459-60. PubMed ID: 14654634
    [No Abstract]   [Full Text] [Related]  

  • 2. Stimulant treatment for ADHD may not increase risk of substance abuse.
    Harv Ment Health Lett; 2008 Jun; 24(12):7. PubMed ID: 18946888
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion.
    Faraone SV; Wilens TE
    J Clin Psychiatry; 2007; 68 Suppl 11():15-22. PubMed ID: 18307377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of attention deficit/hyperactivity disorder and the use of stimulants in prison. Evaluation of the risks and benefits.
    Fructuoso A
    Rev Esp Sanid Penit; 2019; 21(2):113-114. PubMed ID: 31642863
    [No Abstract]   [Full Text] [Related]  

  • 5. Attention deficit hyperactivity disorder in prison.
    Ghanizadeh A; Akhondzadeh S
    J Am Acad Psychiatry Law; 2009; 37(2):278. PubMed ID: 19535565
    [No Abstract]   [Full Text] [Related]  

  • 6. Attention deficit hyperactivity disorder and substance use disorders.
    Bukstein OG
    Curr Top Behav Neurosci; 2012; 9():145-72. PubMed ID: 21789746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulant treatment of ADHD and risk of sudden death in children.
    Vitiello B; Towbin K
    Am J Psychiatry; 2009 Sep; 166(9):955-7. PubMed ID: 19528196
    [No Abstract]   [Full Text] [Related]  

  • 8. Abuse liability of medications used to treat attention-deficit/hyperactivity disorder (ADHD).
    Kollins SH
    Am J Addict; 2007; 16 Suppl 1():35-42; quiz 43-4. PubMed ID: 17453605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central stimulants in the treatment of attention-deficit hyperactivity disorder (ADHD) in children and adolescents. A naturalistic study of the prescription in Sweden, 1977-2007.
    Janols LO; Liliemark J; Klintberg K; von Knorring AL
    Nord J Psychiatry; 2009 Nov; 63(6):508-16. PubMed ID: 19958258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on Attention-Deficit/Hyperactivity Disorder.
    Soileau EJ
    Adolesc Med State Art Rev; 2014 Aug; 25(2):502-19. PubMed ID: 27132328
    [No Abstract]   [Full Text] [Related]  

  • 11. Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? A 13-year prospective study.
    Barkley RA; Fischer M; Smallish L; Fletcher K
    Pediatrics; 2003 Jan; 111(1):97-109. PubMed ID: 12509561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term efficacy of ADHD pharmacotherapy in children.
    Gilchrist RH; Arnold EL
    Pediatr Ann; 2008 Jan; 37(1):46-51. PubMed ID: 18240853
    [No Abstract]   [Full Text] [Related]  

  • 13. An update on attention deficit disorder.
    Harv Ment Health Lett; 2004 May; 20(11):4-7. PubMed ID: 15153391
    [No Abstract]   [Full Text] [Related]  

  • 14. Attention-deficit hyperactivity disorder diagnosis and treatment. Separating myth from substance.
    Barzman DH; Fieler L; Sallee FR
    J Leg Med; 2004 Mar; 25(1):23-38. PubMed ID: 15208788
    [No Abstract]   [Full Text] [Related]  

  • 15. Attention-deficit/hyperactivity disorder and substance abuse.
    Harstad E; Levy S;
    Pediatrics; 2014 Jul; 134(1):e293-301. PubMed ID: 24982106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADHD: disorder or discipline problem?
    Faraone SV; Biederman J
    Science; 2001 Feb; 291(5508):1488-9. PubMed ID: 11234074
    [No Abstract]   [Full Text] [Related]  

  • 17. Does stimulant treatment lead to substance use disorders?
    Faraone SV; Wilens T
    J Clin Psychiatry; 2003; 64 Suppl 11():9-13. PubMed ID: 14529324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attention-Deficit Hyperactivity Disorder.
    DuPont RL
    Essent Psychopharmacol; 2005; 6(5):iv. PubMed ID: 16222908
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety of stimulant treatment in attention deficit hyperactivity disorder: Part I.
    Merkel RL; Kuchibhatla A
    Expert Opin Drug Saf; 2009 Nov; 8(6):655-68. PubMed ID: 19785509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylphenidate-induced psychosis in adult attention-deficit/hyperactivity disorder: report of 3 new cases and review of the literature.
    Kraemer M; Uekermann J; Wiltfang J; Kis B
    Clin Neuropharmacol; 2010 Jul; 33(4):204-6. PubMed ID: 20571380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.